70.69% of retail investor accounts lose money when trading CFDs / Spread betting with this provider.
Important Notice - Scam website
Important Notice - Fraud awareness
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70.69% of retail investor accounts lose money when trading CFDs / Spread betting with this provider. You should consider whether you understand how CFDs / Spread betting work and whether you can afford to take the high risk of losing your money.
Important Notice - Scam website
Important Notice - Fraud awareness
The vast majority of retail investor accounts lose money when trading CFDs / Spread betting with this provider.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The vast majority of retail investor accounts lose money when trading CFDs / Spread betting with this provider. You should consider whether you understand how CFDs / Spread betting work and whether you can afford to take the high risk of losing your money.
ATFX
Language
    rch
    Client Portal
    Client Portal
    Open account
    Start trading
    rch

    The Pfizer share price vaccine boost

    On November 9 the Pfizer share price not only received a shot in the arm from the company’s own groundbreaking COVID-19 vaccine news. It also boosted world stock markets as well as the Pfizer share price. Part of the enthusiasm for the 90% effective / store at -70 centigrade vaccine was clearly the relief of the announcement marking the beginning of the end of the pandemic, both in terms of victims and economies.

    The news could be even more of a breakthrough if as Pfizer has promised it can turn the vaccine into a powder, sidestepping the ultra cold storage issue. However, digging deeper into the news it could be argued that it raises as many questions as it answers for the Pfizer share price. Who will win the COVID-19 vaccine race, as well as what the financial benefits may be to Pfizer shares?

    Learn more about shares trading with ATFX

     

    CEO Albert Bourla sells Pfizer shares

    One of the events that added spice to the Pfizer’s vaccine news was the simultaneous sale on the day of $5.6m worth of Pfizer shares by the CEO of the company. Given the way that share dealings by company executives are one of the most important signals to investors, the timing here for the PFE share price was unfortunate to say the least. In fact, Pfizer said that the deal had been set up as long ago as August, via an automated price limit.

    However, the fact that the stock only rose 15% at the peak on the day can be explained by the way that the Pfizer shares sale by the CEO damaged sentiment, albeit inadvertently. Nevertheless, rather than sentiment surrounding the news, it was the prospects for the company after the development of the vaccine which were key for investors.

     

    How much could Pfizer shares gain from a COVID-19 vaccine?

    There are two key factors for Pfizer with regard to a COVID-19 vaccine. The first is how effective the vaccine is itself. But perhaps more importantly in the wake of Moderna’s 94.5% effective vaccine, whether the COVID-19 vaccine battle will become a race with two or even more horses? If this is the case the estimates in terms of earnings could become far more complex than they may appear currently.

    Current estimates are that Pfizer and partner BioNTech could make up to 1.3bn vaccine doses by the end of 2021. This may make up for the fact that aside from a COVID-19 vaccine the Pfizer share price has been pressured by year on year sales actually declining over the past six quarters. The prospect of this slide being halted could boost Pfizer shares, if the competition from subsequent vaccines such as the latest from Moderna do not undermine its offering.

     

    Pfizer shares need a COVID-19 vaccine boost

    While the arrival of its COVID-19 vaccine is welcome, it is clear that it is timely as well. Across Pfizer’s portfolio in recent years we have seen blockbuster drugs fail relative to rivals. This was particularly underlined in the summer of 2020 with the relative disappointment associated with its breast cancer test Ibrance relative to that of rival Eli Lilly.

     

    How to trade Pfizer shares

    Open a live or demo account with ATFX to get started today. Trade shares on leverage, take up a long or short position when trading with CFDs and make potential gains from price movements.

    1. Register for an account or log in to your existing account

    2. Open MT4 either on your desktop or mobile

    3. Search for Pfizer shares in the market watch or symbols window

    4. Choose your position size

    5. Hit buy or sell, and then confirm the trade

     

    PFE share price daily chart

    Daily chart analysis showing Pfizer share price daily movements for 2020

     

    Looking to learn trading strategies to boost your trading? Check out our Trading Education Center.

    Take the opportunity to develop your trading skills with our free educational resources. Find e-books, in-depth trading courses, MT4 platform guideline videos, trading strategies and more.

    Last Updated: 17/11/2020

    This market commentary and analysis has been prepared for ATFX by a third party for general information purposes only. Any view expressed does not constitute a personal recommendation or solicitation to buy or sell as it does not take into account your personal circumstances or objectives, and should therefore not be interpreted as financial, investment or other advice, or relied upon as such. You should therefore seek independent advice before making any investment decisions. This information has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. We aim to establish and maintain and operate effective organisational and administrative arrangements with a view to taking all reasonable steps to prevent conflicts of interest from constituting or giving rise to a material risk of damage to the interests of our clients. The market data is derived from independent sources believed to be reliable, however we make no representation or warranty of its accuracy or completeness, and accept no responsibility for any consequence of its use by recipients. Reproduction of this information, in whole or in part, is not permitted.


     

    Recent news

    Bitcoin - BTCUSD Cryptocurrencies
    Bitcoin price bubble re-emerges, how high can BTCUSD reach in 2021?

    The mania in cryptocurrencies is back, and Bitcoin prices, BTCUSD, are just 1200 USD from ...

    Shares share price earnings stocks Walmart
    Walmart shares price pandemic challenge

    It can be said that for retailers of all shapes and sizes 2020 to date has been a challeng...

    Indices Shares share price earnings stocks Cineworld
    Cineworld share price could slump to 33 from 44.79 as cash reserves run out

    Cineworld share price had a stellar return of 331.23% from its October low to November hig...

    Shares share price earnings stocks Topps Tiles
    Topps Tiles share price hit by early 2020 profits warning

    It can be said that there are few stocks and sectors outside the pharma area who can prove...

    Shares share price earnings stocks iQIYI
    Bullish sentiment for the iQIYI share price

    It is usually the case that even with the most bullish of stocks and where market sentimen...